These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1463519)

  • 21. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
    Arikawa E; Hoffman EP; Kaido M; Nonaka I; Sugita H; Arahata K
    Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D
    Arch Dis Child; 1993 May; 68(5):632-6. PubMed ID: 8323331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Duchenne muscular dystrophy].
    Ishiura S; Sugita H
    No To Shinkei; 1991 May; 43(5):405-9. PubMed ID: 1910927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The up-regulation of utrophin is not limited to muscular dystrophies.
    Lukás Z
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():87-9. PubMed ID: 10707847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dystrophin assay in muscular dystrophies: an Indian experience.
    Jain S; Sarkar C; Dinda AK; Maheshwari MC
    Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dystrophin, utrophin and beta-dystroglycan expression in skeletal muscle from patients with Becker muscular dystrophy.
    Kawajiri M; Mitsui T; Kawai H; Kobunai T; Tsuchihashi T; Saito S
    J Neuropathol Exp Neurol; 1996 Aug; 55(8):896-903. PubMed ID: 8759779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.
    Ibraghimov-Beskrovnaya O; Ervasti JM; Leveille CJ; Slaughter CA; Sernett SW; Campbell KP
    Nature; 1992 Feb; 355(6362):696-702. PubMed ID: 1741056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creatine kinase, cell membrane and Duchenne muscular dystrophy.
    Ozawa E; Hagiwara Y; Yoshida M
    Mol Cell Biochem; 1999 Jan; 190(1-2):143-51. PubMed ID: 10098981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Muscular dystrophy].
    Tomioka S; Ishiura S
    Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2418-24. PubMed ID: 9366227
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy.
    Mizuno Y; Yoshida M; Nonaka I; Hirai S; Ozawa E
    Muscle Nerve; 1994 Feb; 17(2):206-16. PubMed ID: 8114791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redefinition of dystrophin isoform distribution in mouse tissue by RT-PCR implies role in nonmuscle manifestations of duchenne muscular dystrophy.
    Tokarz SA; Duncan NM; Rash SM; Sadeghi A; Dewan AK; Pillers DA
    Mol Genet Metab; 1998 Dec; 65(4):272-81. PubMed ID: 9889014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers.
    Ohlendieck K
    Eur J Cell Biol; 1996 Jan; 69(1):1-10. PubMed ID: 8825019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of adhalin in a patient with muscular dystrophy and cardiomyopathy.
    McNally EM; Bönnemann CG; Kunkel LM; Bhattacharya SK
    N Engl J Med; 1996 Jun; 334(24):1610-1. PubMed ID: 8628353
    [No Abstract]   [Full Text] [Related]  

  • 35. Dystrophin immunoreactivity in normal and Duchenne human fetal neurons in culture.
    Torelli S; Sogos V; Ennas MG; Muntoni F; Clerk A; Strong PN; Gremo F
    J Neurosci Res; 1992 May; 32(1):116-25. PubMed ID: 1378503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies.
    Hoffman EP; Connor EM
    Discov Med; 2013 Nov; 16(89):233-9. PubMed ID: 24229740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ELISA quantitation of dystrophin for the diagnosis of Duchenne and Becker muscular dystrophies.
    Byers TJ; Neumann PE; Beggs AH; Kunkel LM
    Neurology; 1992 Mar; 42(3 Pt 1):570-6. PubMed ID: 1549217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.
    Jones KJ; Kim SS; North KN
    J Med Genet; 1998 May; 35(5):379-86. PubMed ID: 9610800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of combined DNA and dystrophin protein analysis in the diagnosis of Duchenne's and Becker's muscular dystrophy in 102 Dutch patients].
    Ginjaar HB; Bakker E; Busch HF; Moorman AF; de Visser M; van Ommen JB
    Ned Tijdschr Geneeskd; 1993 Jan; 137(2):68-75. PubMed ID: 8421530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.